CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 88 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2017. The put-call ratio across all filers is 18.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $16,000 | +60.0% | 8,203 | 0.0% | 0.00% | – |
| Q4 2020 | $10,000 | -50.0% | 8,203 | -25.4% | 0.00% | – |
| Q3 2020 | $20,000 | -82.5% | 10,993 | -19.6% | 0.00% | – |
| Q2 2020 | $114,000 | +103.6% | 13,681 | +27.3% | 0.00% | – |
| Q1 2020 | $56,000 | -13.8% | 10,749 | -9.9% | 0.00% | – |
| Q4 2019 | $65,000 | +41.3% | 11,930 | +25.2% | 0.00% | – |
| Q3 2019 | $46,000 | -30.3% | 9,529 | 0.0% | 0.00% | – |
| Q2 2019 | $66,000 | 0.0% | 9,529 | 0.0% | 0.00% | – |
| Q1 2019 | $66,000 | +37.5% | 9,529 | +16.1% | 0.00% | – |
| Q4 2018 | $48,000 | -11.1% | 8,209 | +14.7% | 0.00% | – |
| Q3 2018 | $54,000 | +50.0% | 7,158 | 0.0% | 0.00% | – |
| Q2 2018 | $36,000 | -30.8% | 7,158 | -17.1% | 0.00% | – |
| Q1 2018 | $52,000 | -37.3% | 8,639 | -25.8% | 0.00% | – |
| Q4 2017 | $83,000 | -20.2% | 11,642 | -19.4% | 0.00% | – |
| Q3 2017 | $104,000 | +35.1% | 14,443 | +16.8% | 0.00% | – |
| Q2 2017 | $77,000 | – | 12,366 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $3,107,000 | 1.71% |
| ETF MANAGERS GROUP, LLC | 14,138,998 | $8,534,000 | 0.17% |
| Ikarian Capital, LLC | 948,526 | $584,000 | 0.09% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 318,668 | $196,000 | 0.03% |
| Platform Technology Partners | 45,000 | $28,000 | 0.01% |
| XTX Topco Ltd | 34,476 | $21,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 947,083 | $583,000 | 0.01% |
| Penserra Capital Management LLC | 537,236 | $330,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,070,006 | $2,506,000 | 0.01% |
| Tekla Capital Management LLC | 154,310 | $95,000 | 0.00% |